Celsion Announces Resignation of Vice President and Medical Director
Monday September 13, 3:55 pm ET
COLUMBIA, Md.--(BUSINESS WIRE)--Sept. 13, 2004--CELSION CORPORATION (AMEX:CLN - News) today announced the resignation of Dr. William E. Gannon, as the Company's Vice President--Clinical Affairs and Medical Director. Dr. Gannon has served in those positions since January 2002.
According to Dr. Augustine Cheung, Celsion's President and Chief Executive Officer, the functions previously performed by Dr. Gannon are being carried out by internal clinical staff and medical consultants.
About Celsion: Celsion Corporation, based in Columbia, Maryland, is a biotechnology company dedicated to the development and commercialization of treatment systems for cancer and other diseases using focused-heat energy, either administered alone, or in combination with other therapeutic devices, heat-activated genes or heat-activated drugs.
Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, Massachusetts Institute of Technology, Harbor UCLA Medical Center, Montefiore Medical Center and Memorial Sloan-Kettering Cancer Center in New York City, Roswell Park Cancer Institute in Buffalo, New York and Duke University. For more information on Celsion, visit our website: www.celsion.com.
biz.yahoo.com
Hmmm .. is this good, bad, or indifferent?
Why would they put the PR out at 3:55pm, instead of 4:01pm? Interesting. |
